Equine Healthcare Market Size & Growth Forecast 2027–2036, By Segments (Product Type, Activity, Distribution Channel, Indication), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growth Outlook
Equine Healthcare Market size was more than USD 5.03 Billion in 2026 and is set to grow at a 10.36% CAGR between 2027 and 2036, attaining USD 13.48 Billion by 2036. The industry revenue for 2027 is assessed at USD 5.47 Billion.
Get more details on this report
Request Free Sample ReportEquine Healthcare Market Intelligence Snapshot
Regional Market Dynamics
- North America holds 34.87% share due to strong veterinary infrastructure, high horse ownership, and widespread use of preventive care, diagnostics, and advanced treatment services.
- Asia Pacific’s 9.49% CAGR is driven by rising investment in veterinary care, growing equestrian activity, and increasing shift toward preventive health and structured horse management practices.
Segment Momentum
- Pharmaceuticals accounted for 28.18% of the market in 2026 due to their broad use in managing infections, inflammation, pain, parasitic conditions, and ongoing health maintenance across equine care settings.
- Orthobiologics is the fastest-growing product type as veterinarians and horse owners increasingly adopt regenerative approaches to improve recovery outcomes for musculoskeletal injuries in active and performance horses.
Market Expansion Drivers
- Rising equine sports participation and performance demands increasing veterinary healthcare utilization.
- Increasing prevalence of infectious and parasitic diseases in horse populations driving treatment demand.
- Expanding equine nutrition, supplements, and preventive care adoption supporting long-term animal health.
Leading Market Participants
- Prominent companies in the equine healthcare market include Zoetis Inc. (United States), Boehringer Ingelheim International GmbH (Germany), Elanco Animal Health Incorporated (United States), Dechra Pharmaceuticals PLC (United Kingdom), Merck & Co., Inc. (United States), Ceva Santé Animale (France), IDEXX Laboratories, Inc. (United States), Covetrus, Inc. (United States), Heska Corporation (United States), Cargill, Incorporated (United States).
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 5.03 Billion
- 2027 Estimated Market Size: USD 5.47 Billion.
- Projected Market Size: USD 13.48 Billion by 2036
- Growth Forecast: 10.36% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: Pharmaceuticals (Product Type) | Sports/Racing (Activity) | Veterinary Hospitals & Clinics (Distribution Channel) | Parasitic Infections (Indication)
- Emerging Opportunity Segment: Orthobiologics (Product Type) | Recreation (Activity) | E-commerce (Distribution Channel) | Musculoskeletal Disorders (Indication)
Market Growth Drivers and Industry Trends
Rising equine sports participation and performance demands increasing veterinary healthcare utilization
Growing participation in equine sports and increasing expectations for animal performance are supporting the equine healthcare market by raising the need for regular veterinary assessment, injury management, and performance-related care. Competition horses are subject to physical demands that can increase the importance of preventive examinations, rehabilitation, diagnostic services, and therapeutic interventions. Owners and trainers also place greater emphasis on maintaining mobility, fitness, and recovery, encouraging more frequent utilization of veterinary healthcare services around training and competition activities.
Increasing prevalence of infectious and parasitic diseases in horse populations driving treatment demand
The occurrence of infectious and parasitic diseases among horse populations is increasing the equine healthcare market demand for diagnostic, pharmaceutical, and veterinary treatment solutions. Disease prevention and timely intervention are particularly important in settings where horses are housed, transported, or managed in groups, as health conditions can affect multiple animals and disrupt routine activities. Greater attention to disease surveillance, parasite control, vaccination, and veterinary diagnosis is therefore increasing the use of healthcare products and services for maintaining horse health.
Expanding equine nutrition, supplements, and preventive care adoption supporting long-term animal health
Greater awareness of the relationship between nutrition, physical condition, and disease prevention is driving the equine healthcare market as owners increasingly incorporate supplements and preventive care into routine horse management. Nutritional products can be used to support areas such as joint function, digestive health, muscle condition, and overall wellness, while preventive programs can help identify or manage health concerns before they become more severe. This shift toward proactive care is broadening healthcare utilization beyond treatment of acute conditions.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rising equine sports participation and performance demands increasing veterinary healthcare utilization | 2.00% | Moderate | North America, Europe | High | Near Term |
| Increasing prevalence of infectious and parasitic diseases in horse populations driving treatment demand | 1.80% | High | North America, Asia Pacific | High | Near Term |
| Expanding equine nutrition, supplements, and preventive care adoption supporting long-term animal health | 1.50% | Moderate | Europe, North America, Asia Pacific | Medium | Mid Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America (Largest Region)
North America dominated the equine healthcare market with a 34.87% share in 2026, reflecting its well-established equestrian ecosystem, strong veterinary infrastructure, and high levels of expenditure on animal health and preventive care. The region benefits from widespread participation in recreational, sporting, breeding, and performance-related equine activities, creating consistent demand for diagnostics, therapeutics, nutritional support, and routine veterinary services. Advanced veterinary capabilities and greater awareness of preventive healthcare also encourage owners and operators to pursue early diagnosis and comprehensive management of equine health conditions. In addition, established supply chains and specialized veterinary expertise provide a strong foundation for continued market development.
Asia Pacific (Fastest-Growing Region)
Asia Pacific is emerging as the fastest-growing regional market, supported by expanding interest in equestrian sports, improving veterinary infrastructure, and increasing awareness of professional equine care. Growing investment in breeding, training, racing, and recreational riding is broadening the need for specialized healthcare services and products. Improvements in veterinary education and diagnostic capabilities are helping address previously underserved healthcare requirements, while rising disposable incomes in several markets are enabling greater spending on animal wellness and performance management. The gradual development of organized equestrian facilities and professional animal-care practices is further creating opportunities for suppliers of advanced equine healthcare solutions.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
Germany 🇩🇪
Veterinary precision treatmentIn Germany, equine healthcare market activity is shaped by high standards in veterinary medicine and structured animal health systems. Germany prioritizes precision diagnostics and preventive treatment protocols, with strong focus on equine sports and recreational horse management.
France 🇫🇷
Strong equestrian tradition baseIn France, equine healthcare market activity is influenced by strong equestrian traditions and established veterinary networks. France emphasizes comprehensive horse health management, particularly for sport and leisure horses, supported by structured veterinary service ecosystems.
Italy 🇮🇹
Recreational equine maintenanceIn Italy, equine healthcare market demand is driven by recreational horse ownership and equestrian tourism. Italy prioritizes routine veterinary care and preventive treatments, with steady demand for maintaining horse health across leisure and sport applications.
Japan 🇯🇵
Niche equine care specializationIn Japan, equine healthcare market demand is relatively niche but highly specialized, centered on racing and select recreational use. Japan emphasizes controlled veterinary care practices and targeted treatment solutions for performance and breeding horses.
South Korea 🇰🇷
Emerging equine infrastructureIn South Korea, equine healthcare market demand is supported by emerging horse sports infrastructure and recreational equestrian development. South Korea focuses on expanding veterinary capabilities and preventive healthcare solutions for a growing equine population.
United States 🇺🇸
Performance horse care ecosystemIn the U.S., equine healthcare market demand is driven by a large performance horse industry and advanced veterinary infrastructure. The U.S. emphasizes preventive care, advanced diagnostics, and sports medicine applications supporting racing, competition, and recreational equine populations.
Segment Leadership and Growth Trends
Equine Healthcare Market Share (%), by Product Type, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportProduct Type Segment Analysis: Pharmaceuticals (Largest Segment) vs Orthobiologics (Fastest-Growing Segment)
Pharmaceuticals held the largest share of 28.18% in 2026 in the equine healthcare market, reflecting their broad use across disease prevention, infection management, pain control, inflammation management, and other routine veterinary needs. Pharmaceutical products remain an essential part of equine care because horses involved in athletic, recreational, and working activities require timely management of both acute and chronic health conditions. Increasing emphasis on preventive veterinary care and improved access to specialized animal health services are supporting continued demand. The availability of established therapeutic approaches for a wide range of equine conditions also gives pharmaceuticals a strong foundation across veterinary practices and horse-care environments.
Orthobiologics represent the fastest-growing product type as veterinarians and horse owners increasingly seek regenerative approaches that can support tissue repair and functional recovery. These therapies are particularly relevant to musculoskeletal conditions, where maintaining mobility and restoring performance are important considerations. Greater interest in advanced treatment options for tendon, ligament, joint, and other orthopedic injuries is encouraging adoption of biologically focused therapies. The increasing integration of regenerative medicine into equine veterinary practice, combined with growing awareness of approaches designed to support natural healing processes, is strengthening the growth prospects of orthobiologics.
Activity Segment Analysis: Sports/Racing (Largest Segment) vs Recreation (Fastest-Growing Segment)
Sports/Racing accounted for the largest share in 2026, making it the leading activity segment in the equine healthcare market, as performance horses require consistent veterinary support to maintain health, mobility, conditioning, and competitive readiness. Intensive physical activity can increase the importance of injury prevention, rehabilitation, nutritional management, and routine health monitoring. Owners and trainers involved in competitive equine activities are therefore more likely to invest in specialized veterinary care and advanced treatment approaches when performance or recovery is affected. The growing focus on maintaining athletic longevity and managing musculoskeletal health continues to reinforce the importance of the sports and racing segment.
Recreation is the fastest-growing activity segment as horses increasingly participate in leisure riding, trail activities, companionship, and other non-competitive uses that encourage owners to prioritize long-term animal health. Recreational horse owners are becoming more attentive to preventive veterinary care, mobility, nutrition, and overall well-being, expanding demand beyond performance-focused applications. Greater awareness of equine wellness and improved access to veterinary services are encouraging owners to address health concerns earlier. This broader shift toward comprehensive care and quality of life is creating stronger opportunities for healthcare products and services within recreational equine populations.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Product Type | Vaccines, Pharmaceuticals, Medicinal Feed Additives, Orthobiologics, Diagnostics, Software & Services, Others | Pharmaceuticals | Orthobiologics |
| Activity | Sports/Racing, Recreation, Others | Sports/Racing | Recreation |
| Distribution Channel | Veterinary Hospitals & Clinics, E-commerce, Equestrian Facilities, Others | Veterinary Hospitals & Clinics | E-commerce |
| Indication | Musculoskeletal Disorders, Parasitic Infections, Equine Herpes Virus, Equine Viral Arteritis (EVA), Equine Influenza, West Nile Virus, Tetanus, Others | Parasitic Infections | Musculoskeletal Disorders |
Competitive Landscape and Market Positioning
Prominent players in the equine healthcare market:
1. Zoetis Inc. (United States)
2. Boehringer Ingelheim International GmbH (Germany)
3. Elanco Animal Health Incorporated (United States)
4. Dechra Pharmaceuticals PLC (United Kingdom)
5. Merck & Co. Inc. (United States)
6. Ceva Santé Animale (France)
7. IDEXX Laboratories Inc. (United States)
8. Covetrus Inc. (United States)
9. Heska Corporation (United States)
10. Cargill Incorporated (United States)
The equine healthcare market is evolving through increased adoption of digital veterinary solutions, advanced diagnostics, and next-generation therapeutic approaches aimed at improving animal care standards. Industry participants are strengthening research capabilities and collaborative networks to enhance treatment accessibility and optimize healthcare delivery for equine populations. The growing integration of telemedicine platforms and data-driven health monitoring tools is also contributing to competitive differentiation across the equine healthcare market.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| Zoetis Inc. (United States) | |||||||
| Boehringer Ingelheim International GmbH (Germany) | |||||||
| Elanco Animal Health Incorporated (United States) | |||||||
| Dechra Pharmaceuticals PLC (United Kingdom) | |||||||
| Merck & Co. Inc. (United States) | |||||||
| Ceva Santé Animale (France) | |||||||
| IDEXX Laboratories Inc. (United States) | |||||||
| Covetrus Inc. (United States) | |||||||
| Heska Corporation (United States) | |||||||
| Cargill Incorporated (United States). |
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| Equine Care Group | May-26 | Equine Care Group has expanded its international footprint into the United States through a strategic partnership with Salado Equine Medical Center in Texas. This acquisition marks the group’s first U.S. presence, enabling the integration of its veterinary service network and improving access to advanced diagnostic and treatment services within the North American equine healthcare market. |
| Zomedica | Dec-25 | Zomedica has launched a dedicated equine progesterone assay for its TRUFORMA® in-clinic biosensor platform. This addition expands point-of-care diagnostic capabilities for veterinarians and breeders, allowing for the quantitative assessment of reproductive function and pregnancy maintenance in mares, thereby improving breeding efficiency and clinical reproductive outcomes. |
| Chewy | Oct-25 | Chewy has entered a definitive agreement to acquire the SmartEquine business from Covetrus. This acquisition incorporates SmartEquine’s premium portfolio of subscription-based supplements, personalized nutrition plans, and therapeutic products into Chewy’s healthcare ecosystem, strengthening the company's position in the high-margin equine wellness segment and enhancing its service offerings for equine owners nationwide. |
| bioMérieux | Jun-25 | bioMérieux has launched VETFIRE™, a ready-to-use PCR diagnostic kit designed for the rapid detection of seven equine infectious respiratory pathogens. By delivering results in under 20 minutes via the BIOFIRE® SPOTFIRE® platform, the technology enables veterinarians to make point-of-care decisions regarding treatment and quarantine, significantly improving the management of respiratory disease outbreaks in clinical and stable environments. |
| Sleip | Jun-24 | Sleip has expanded the deployment of its AI-driven diagnostic platform designed for the detection and monitoring of equine lameness. By integrating artificial intelligence into standard veterinary workflows, the platform enables objective, data-driven analysis of gait abnormalities, supporting advanced clinical decision-making and improving the precision of performance monitoring for high-value equine athletes. |
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
Equine Healthcare Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Care Objective | Preventive Care, Therapeutic Care, Rehabilitation & Recovery, Performance & Wellness Management |
| Ownership Type | Individual Horse Owners, Professional Trainers & Racing Operations, Equestrian Facilities, Breeding & Stud Operations |
| Care Expenditure Tier | Basic Care, Standard Care, Premium Care, Specialized High-Value Care |
Equine Healthcare Market — Custom
| Custom Chapter | Custom Details |
|---|---|
| Equine Disease Burden and Treatment Demand |
|
| Equine Sports and Performance Healthcare Opportunities |
|
| Owner Spending and Preventive Care Adoption |
|
Need a different cut of the data?
Request Custom ResearchWhat is the market size of equine healthcare?
How is the equine healthcare industry projected to perform over the next decade?
How is preventive healthcare changing spending priorities in the equine healthcare market?
Why is equine sports participation driving higher veterinary healthcare utilization?
Why do Pharmaceuticals hold the largest share of the equine healthcare market?
What is fueling the growth of Orthobiologics in the equine healthcare market?
Why does North America lead the equine healthcare market?
What is driving Asia Pacific growth in the equine healthcare market?
Which organizations are considered leaders in the equine healthcare landscape?
Our Clients
"The reports offered a comprehensive view of the Food and Beverage landscape, covering market trends, consumer behavior, and competitive dynamics."
"Our experience in acquiring market research reports has been outstanding — the depth of analysis and actionable insights have proven invaluable."
"Fundamental Business Insights demonstrated a keen understanding of our business needs, delivering reports tailored to our specific objectives."
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source | Why It Matters | Reference |
|---|---|---|
| World Health Organization (WHO) | Global health statistics, disease burden, healthcare policies | www.who.int |
| U.S. Food & Drug Administration (FDA) | Medical devices, pharmaceuticals, diagnostics, approvals | www.fda.gov |
| European Medicines Agency (EMA) | Pharmaceutical approvals and regulatory guidance in Europe | www.ema.europa.eu |
| Centers for Disease Control and Prevention (CDC) | Disease surveillance, public health, epidemiology | www.cdc.gov |
| National Institutes of Health (NIH) | Biomedical research, clinical studies, funding | www.nih.gov |
| National Center for Biotechnology Information (NCBI) | Biomedical databases, PubMed, genomics | www.ncbi.nlm.nih.gov |
| PubMed | Peer-reviewed biomedical literature | pubmed.ncbi.nlm.nih.gov |
| ClinicalTrials.gov | Global clinical trial registry | clinicaltrials.gov |
| International Organization for Standardization (ISO) | Medical device quality and healthcare standards | www.iso.org |
| ASTM International | Medical device testing and material standards | www.astm.org |
| Advanced Medical Technology Association (AdvaMed) | Medical devices and diagnostics industry | www.advamed.org |
| Medical Device Innovation Consortium (MDIC) | Medical device innovation and regulatory science | mdic.org |
| Biotechnology Innovation Organization (BIO) | Biotechnology industry developments | www.bio.org |
| International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) | Global pharmaceutical industry | www.ifpma.org |
| U.S. Pharmacopeia (USP) | Drug quality standards and reference materials | www.usp.org |
| European Directorate for the Quality of Medicines & HealthCare (EDQM) | European pharmaceutical quality standards | www.edqm.eu |
| World Organisation for Animal Health (WOAH) | Veterinary healthcare and animal diseases | www.woah.org |
| American Hospital Association (AHA) | Hospital operations and healthcare delivery | www.aha.org |
| OECD Health | International healthcare expenditure and system statistics | www.oecd.org/health |
| World Bank Data | Healthcare expenditure and demographic indicators | data.worldbank.org |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization